Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP+-induced model of Parkinson’s disease
2024

How Compound Dihuang Granule Helps Protect Neurons in Parkinson's Disease

Sample size: 44 publication 10 minutes Evidence: high

Author Information

Author(s): Sun Xue, Yang Shuai, He Zhuqing, Wang Li, He Jiancheng

Primary Institution: Shanghai University of Traditional Chinese Medicine

Hypothesis

The study aims to explore the molecular mechanisms by which Compound Dihuang Granule (CDG) protects dopaminergic neurons from ferroptosis in Parkinson's disease.

Conclusion

CDG protects dopaminergic neurons from ferroptosis by regulating the Nrf2/HMOX1 pathway.

Supporting Evidence

  • CDG improved the neurobehavior of PD rats by alleviating dopamine neuron damage.
  • CDG decreased levels of MDA, ROS, and Fe2+ while increasing GSH levels.
  • RNA-seq analysis showed differential genes were enriched in Nrf2 and HMOX1 pathways.

Takeaway

This study shows that a traditional Chinese medicine called Compound Dihuang Granule can help protect brain cells in people with Parkinson's disease by stopping a harmful process called ferroptosis.

Methodology

The study used network pharmacology, LC-MS, RNA sequencing, and in vivo and in vitro experiments to validate the findings.

Participant Demographics

Sprague Dawley rats, aged 8 weeks, weighing 180±20g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13020-024-01040-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication